Sign up to save your podcasts
Or
Share Short Shorts for 3rd Week of August, 2022
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Short Shorts for 3rd Week of August, 2022
Vidcast: https://youtu.be/pHgQ9JsvwDo
Here are the latest cutting edge medical and healthcare discoveries this 3rd Week of August, 2022. Many of discoveries will become the therapies of tomorrow.
MIT bioengineers have developed self-powered wearable wireless sensors capable of transmitting data about pulse rate, sweat composition, and ultraviolet radiation exposure. What’s unique about these wearables is that they perform this monitoring without embedded Bluetooth chips or batteries. The ultrathin sensing film is composed of gallium nitride with 2-way piezoelectric properties allowing it to both sense underlying skin changes and complete wireless transmission of the collected data when paired with a conducting layer of gold.
https://www.science.org/doi/10.1126/science.abn7325
The placenta is known as the “engine of pregnancy” since it provides oxygen and vital nutrients to the developing fetus. University of Pennsylvania researchers now report a unique method for monitoring placental function and blood flow utilizing a unique combination of ultrasound and optical spectroscopy. Light and sound waves are simultaneously directed through the pregnant woman’s abdomen, and the reflected light is amplified and background noise removed to permit quantification of placental oxygen levels. This precise placental monitoring permits better management of hight risk pregnancies.
https://www.nature.com/articles/s41551-022-00913-2
A newly synthesized peptide called A1R-CT is capable of suppressing seizures when introduced into the body in a nasal spray. Neurologic researchers at the University of Alabama-Birmingham have shown that this protein facilitates activation of the A1 receptor on neurons that squelches excess electrical activity and seizures. These epileptic seizures that commonly accompany strokes, traumatic brain injuries, and neurodegenerative diseases including Alzheimer’s are poorly controlled by conventional agents in some 40% of patients. The A1R-CT nasal spray may help solve this problem.
https://insight.jci.org/articles/view/155002
And finally…..More news about uniquely therapeutic nasal sprays. Looking to create nasal lining immunity where the CoVid virus first enters the body, MIT researchers have successfully fused CoVid receptor binding domain spike antigens with an albumin-binding polymer lipid that opens a portal into nasal linings so that the CoVid proteins can effectively trigger a vigorous, local immune response against themselves. The hope is that effective nasal IgA antibody immunity will offer better protection against the latest group of Omicron subvariants including BA.5.
https://www.science.org/doi/10.1126/scitranslmed.abn1413
There you have the cutting edge medical and healthcare discoveries this 3rd Week of August, 2022.
View all episodes
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/pHgQ9JsvwDo
Here are the latest cutting edge medical and healthcare discoveries this 3rd Week of August, 2022. Many of discoveries will become the therapies of tomorrow.
MIT bioengineers have developed self-powered wearable wireless sensors capable of transmitting data about pulse rate, sweat composition, and ultraviolet radiation exposure. What’s unique about these wearables is that they perform this monitoring without embedded Bluetooth chips or batteries. The ultrathin sensing film is composed of gallium nitride with 2-way piezoelectric properties allowing it to both sense underlying skin changes and complete wireless transmission of the collected data when paired with a conducting layer of gold.
https://www.science.org/doi/10.1126/science.abn7325
The placenta is known as the “engine of pregnancy” since it provides oxygen and vital nutrients to the developing fetus. University of Pennsylvania researchers now report a unique method for monitoring placental function and blood flow utilizing a unique combination of ultrasound and optical spectroscopy. Light and sound waves are simultaneously directed through the pregnant woman’s abdomen, and the reflected light is amplified and background noise removed to permit quantification of placental oxygen levels. This precise placental monitoring permits better management of hight risk pregnancies.
https://www.nature.com/articles/s41551-022-00913-2
A newly synthesized peptide called A1R-CT is capable of suppressing seizures when introduced into the body in a nasal spray. Neurologic researchers at the University of Alabama-Birmingham have shown that this protein facilitates activation of the A1 receptor on neurons that squelches excess electrical activity and seizures. These epileptic seizures that commonly accompany strokes, traumatic brain injuries, and neurodegenerative diseases including Alzheimer’s are poorly controlled by conventional agents in some 40% of patients. The A1R-CT nasal spray may help solve this problem.
https://insight.jci.org/articles/view/155002
And finally…..More news about uniquely therapeutic nasal sprays. Looking to create nasal lining immunity where the CoVid virus first enters the body, MIT researchers have successfully fused CoVid receptor binding domain spike antigens with an albumin-binding polymer lipid that opens a portal into nasal linings so that the CoVid proteins can effectively trigger a vigorous, local immune response against themselves. The hope is that effective nasal IgA antibody immunity will offer better protection against the latest group of Omicron subvariants including BA.5.
https://www.science.org/doi/10.1126/scitranslmed.abn1413
There you have the cutting edge medical and healthcare discoveries this 3rd Week of August, 2022.